Form 483

Navajo Manufacturing Company Form 483, 2011-01-28

FDA issued a Form 483 to Navajo Manufacturing Company on 2011-01-28 with 9 public-safe observations.

483· Form 483 issued9 observations

Navajo Manufacturing Company · Denver, United States · Issued January 28, 2011

Overview

  • 9 public-safe observations are available for this inspection.
  • 9 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Jan 2011
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Linda M Cherry

28 Jan 2011
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Linda M Cherry

28 Jan 2011
21 CFR 211.68(b)

input/output verification

Cited by Linda M Cherry

28 Jan 2011
21 CFR 211.150(b)

Distribution Recall System

Cited by Linda M Cherry

28 Jan 2011
21 CFR 211.165(f)

Failing drug products not rejected

Cited by Linda M Cherry

Inspected site

NMNavajo Manufacturing CompanyDenver, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.150(b)Cited across public-safe Form 483 observations1x
21 CFR 211.165(f)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 211.186(a)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.198(a)Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere